The Trump administration's decision to restrict indirect costs for NIH research grants, as critiqued by Rep. Rosa DeLauro, faces backlash for endangering vital medical research. With $35 billion allocated for research in 2023, $9 billion of that is earmarked for indirect costs, which may now be cut. DeLauro warns such measures could cause irreparable harm to ongoing work on diseases like cancer and Alzheimer's. Experts believe that these new restrictions might not curb spending but instead stifle scientific progress that can save lives.
Rep. Rosa DeLauro cautioned that limiting NIH grants could inflict "irreparable damage" on crucial research for diseases that impact American families, including cancer and Alzheimer's.
The NIH's memo emphasized that $9 billion of the $35 billion research grants in 2023 went to indirect costs, arguing for more funds to direct scientific research.
Experts countered that instead of improving medical research capabilities, the new restrictions could halt lifesaving research experiments across the nation.
OPERA's memo suggested that the allocation of 27-28% of grant funding to indirect costs hinders the U.S.'s potential to lead in global medical research.
Collection
[
|
...
]